UK Markets closed

Bio-Rad Laboratories, Inc. (BIO-B)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
769.89+16.94 (+2.25%)
At close: 12:19PM EST
Full screen
Trade prices are not sourced from all markets
Previous close720.35
Open769.89
Bid769.75 x 1400
Ask772.74 x 800
Day's range769.89 - 769.89
52-week range540.45 - 818.60
Volume116
Avg. volume100
Market cap24.432B
Beta (5Y monthly)0.87
PE ratio (TTM)5.67
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • Business Wire

    Bio-Rad Reports Third-Quarter 2021 Financial Results

    HERCULES, Calif., October 28, 2021--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced financial results for the third quarter ended September 30, 2021.

  • Business Wire

    Bio-Rad to Report Third-Quarter 2021 Financial Results, Thursday, October 28, 2021

    HERCULES, Calif., October 15, 2021--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, will report financial results for the third quarter 2021 on Thursday, October 28, 2021, following the close of the market. The company will discuss these results in a conference call scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.

  • Business Wire

    Bio-Rad to Participate in the 2021 Virtual Wells Fargo Healthcare Conference

    HERCULES, Calif., August 31, 2021--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that management will participate in a Fireside Chat at the 2021 Virtual Wells Fargo Healthcare Conference on Thursday, September 9, at 11:40 AM (Pacific Time).